Clinical Trial Update: Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral dydrogesterone as luteal phase support in natural-cycle frozen embryo transfer for subfertility; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subfertility

Drugs mentioned

• Dydrogesterone (dydrogesterone)

Snippet

Sponsor: The University of Hong Kong | Conditions: Subfertility | Phase 3 | Status: RECRUITING